Key stat: 63% of millennials and 61% of Gen Zers feel more connected to health brands since starting GLP-1s, per a January Dentsu report.

Beyond the chart:

• 23% of US adults are currently using a GLP-1, per a March KPMG survey.
• About half (49%) of GLP-1 users pay more attention to food labels since starting the medication, per Dentsu.

Use this chart: Marketers and retailers can use this chart to consider how the rise of GLP-1s aligns with growing consumer investment in health and wellness.

Related EMARKETER reports:

• The Impact of Weight Loss Drugs 2025 (EMARKETER subscription required)
• Health Trends to Watch in 2025 (EMARKETER subscription required)

Methodology: Data is from the Febraury 2025 Dentsu report titled "GLP-1s: Impact on Consumer Categories" conducted by Toluna. 1,000 US adults ages 18+, including 200 who have ever been on a GLP-1 drug, were surveyed during January 20, 2025. Data was weighted to be nationally representative across age, gender, region, race, and ethnicity (using the latest publicly available US Ccnsus numbers).